Skip to content
healthcare.dev

gabapentin

NDC 50228-523, gabapentin, tablet, from ScieGen Pharmaceuticals, Inc..

Product NDC
50228-523
Status
Listed
Labeler
ScieGen Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218491
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50228-523 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GABAPENTIN300 mg/1

Pharmacologic classes

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
50228-523-0550228052305500 TABLET in 1 BOTTLE (50228-523-05)
50228-523-305022805233030 TABLET in 1 BOTTLE (50228-523-30)
50228-523-905022805239090 TABLET in 1 BOTTLE (50228-523-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3f2e3ac5-5233-fd57-e063-6294a90a849e
  • NADAC price for package 50228052390

    GET /v1/drugs/nadac/50228052390

Use it

Look up 50228-523 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50228-523 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50228-523. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.